Jci_page_head_homepage_01 Jci_page_head_homepage_02
Marc K. Hellerstein, Rebecca A. Hoh, Mary Beth Hanley, Denise Cesar, Daniel Lee, Richard A. Neese, Joseph M. McCune
Published in Volume 112, Issue 6
J Clin Invest. 2003; 112(6):956–966 doi:10.1172/JCI17533
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

In vivo stable isotope labeling protocols. (a) Long-term 2H2O administration. 2H2O was given daily for 9 weeks after a priming regimen. T cells and monocytes/granulocytes were sampled at times shown. Urine and saliva were sampled as shown, to measure body 2H2O enrichment. (b) 2H2-glucose incorporation/die-away curves. 2H2-glucose was given over 48 hours with follow-up blood draws for T cells as shown. Blood glucose enrichments were measured during the i.v. 2H2-glucose infusion. Mono/granulo, monocytes/granulocytes; Glc, glucose. Arrows indicate times of stable isotope label administration or sample collection.